Pulsus Group is glad to announce the 2019 conference in the Breast Cancer series, the  2rd World Congress on Breast Cancer. It is going to be held on September 16-17, 2019 at Edinburgh, Scotland.

Breast Cancer 2019 will be organized around the theme “Keeping the fight alive, Breast Cancer Awareness is what we strive”.

Breast Cancer 2019 is comprised of many interactive scientific sessions on Breast Cancer as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under one roof to explore every single aspect of Breast Cancer.

The conference invites Breast Cancer Surgeons, Women Health care professionals, Pathologists, Oncologists, Researchers, Students, Young researchers and business delegates across the globe to be a part of conference.

The global breast cancer drugs market size was valued at 16.98 billion in 2017 and is expected to register at a CAGR of 10.7% over the forecast period. Rising prevalence of the disease along with emerging novel therapies are some of the major factors likely to drive the market. Early detection of breast cancer is a key to effective management of the disease.

Breast Cancer 2019 will provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation, B2B and Scientific Meetings.

Why to attend?

Breast Cancer 2019 will provide a stimulating scientific environment and a platform for the participants to exchange ideas, establish research collaboration and networking. It will be an amazing opportunity for the attendees to explore the beautiful city, at the same time, helps to gain knowledge in the field of Breast Cancer which will surely help to raise insights, conflate present with future and cogitate ideas in Breast Cancer. To fight against the obstacles to cure Breast Cancer.

Breast Cancer 2019 has taken this initiative to explore every aspect of Breast Cancer research.

Target Audience

Oncologists

Immunologists

Pathologists

Surgeons

Health Care professional

Research Scholars

Students